EMA starts review of latecomer GSK/Sanofi COVID-19 vaccine

Retrieved on: 2021-07-20 15:33:45

Tags for this article:

Click the tags to see associated articles and topics

EMA starts review of latecomer GSK/Sanofi COVID-19 vaccine. View article details on hiswai:

Excerpt

So far the EU has approved four COVID-19 vaccines – two mRNA shots from Pfizer/BioNTech and Moderna, and two based on adenoviral vectors ...

Article found on: pharmaphorum.com